GO:0070402 NADPH binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070402 (NADPH binding) is a molecular function describing the selective, non-covalent interaction of a protein with the reduced coenzyme NADPH, distinct from NADH binding.
• NADPH binding is the molecular prerequisite for hydride transfer in reductive biosynthesis, antioxidant defense, and phagocyte superoxide production.
• Canonical NADPH-binding proteins use a Rossmann-fold glycine-rich motif (GxGxxG) to coordinate the 2'-phosphate of the adenosine ribose.
• NADPH binding is not limited to enzymes: it allosterically regulates voltage-gated K+ channel inactivation through the Kvbeta subunit.
• Some enzymes, such as chanoclavine synthase, operate through an NADPH-independent superoxide mechanism, showing that NADPH binding is not universally required for redox catalysis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of NADPH-binding residues and their disease relevance.
Description
GO:0070402, NADPH binding, is a Gene Ontology molecular function term defined as binding to the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions. In practical terms, it describes the selective, non-covalent association of a protein with NADPH, the principal intracellular electron donor for reductive biosynthesis and antioxidant defense. Because NADPH differs from NADH only by the 2'-phosphate on the adenosine ribose, proteins that bind NADPH must discriminate between these two coenzymes, often through a dedicated 2'-phosphate binding pocket. This selectivity is central to metabolic compartmentalization and signaling fidelity. Researchers study NADPH binding because it underlies diverse physiological processes, including glutathione reduction, lipid and sterol biosynthesis, and the respiratory burst of phagocytes. Structural and biochemical studies have shown that NADPH binding can be coupled to large-scale conformational changes, as in the activation of the phagocyte NADPH oxidase complex. In other systems, NADPH binding to a non-catalytic subunit modulates ion channel gating, demonstrating that the function extends beyond classical redox enzymology. From a disease and drug-discovery perspective, NADPH-binding sites are attractive targets because they control flux through reductive pathways and influence oxidative stress responses. Understanding the precise determinants of NADPH recognition, including the Rossmann-fold motif and the 2'-phosphate specificity pocket, enables rational design of inhibitors and CRISPR-based functional studies. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0070402.
NADPH binding At A Glance
| GO ID | GO:0070402 |
|---|---|
| GO term | NADPH binding |
| Ontology | molecular_function |
| Synonym | NADP (reduced) binding; reduced NADP binding; reduced nicotinamide adenine dinucleotide phosphate binding |
| Definition | Binding to the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions. |
| Major function | Selective recognition of NADPH to support hydride transfer, reductive biosynthesis, antioxidant defense, and allosteric regulation. |
| Structural motif | Often a Rossmann-fold glycine-rich motif (GxGxxG) that coordinates the NADPH 2'-phosphate. |
| Representative proteins | Glutathione reductase, phagocyte NADPH oxidase subunits, Kvbeta, lipocalin-type prostaglandin D synthase, glutamate dehydrogenase. |
| Related coenzyme | NADH binding (distinct but structurally related); NADPH is the phosphorylated reduced form. |
What Is GO:0070402?
NADPH binding (GO:0070402) is the molecular function of selectively and non-covalently interacting with NADPH, the reduced form of nicotinamide-adenine dinucleotide phosphate. NADPH is a coenzyme that carries reducing equivalents and participates in many redox and biosynthetic reactions. Proteins annotated with this term possess a binding site that accommodates the NADPH molecule, typically recognizing the 2'-phosphate group that distinguishes NADPH from NADH. The binding event may be transient or stable and can be coupled to catalysis, allosteric regulation, or structural stabilization.
Why Is NADPH binding Important in Cell Biology?
NADPH binding is important because it governs the flow of reducing equivalents into anabolic and cytoprotective pathways, and because its dysregulation is linked to oxidative stress, metabolic disease, and immune dysfunction. The selectivity of NADPH binding over NADH determines which coenzyme pool a protein accesses, thereby influencing metabolic compartmentalization and signaling. In phagocytes, NADPH binding to the oxidase complex is essential for superoxide production and host defense. In ion channels, NADPH binding to auxiliary subunits can tune electrical excitability. Consequently, NADPH-binding sites are both mechanistic hubs and potential therapeutic targets.
• NADPH binding provides the reduced coenzyme for glutathione reductase and other disulphide reductases, supporting cellular antioxidant capacity.
• It is required for the phagocyte respiratory burst, where NADPH oxidase transfers electrons to oxygen to generate superoxide.
• NADPH binding can allosterically regulate voltage-gated K+ channel inactivation via the Kvbeta subunit.
• It enables reductive biosynthesis of lipids, sterols, and nucleotides by supplying hydride equivalents.
• Selective NADPH versus NADH binding is determined by recognition of the 2'-phosphate group, a key specificity determinant.
• NADPH binding to lipocalin-type prostaglandin D synthase has been characterized thermodynamically and by NMR, revealing binding-linked conformational effects.
• Glutamate dehydrogenase binds both NADH and NADPH, and spectroscopic studies have resolved differences in their binding modes.
• Some redox enzymes, such as chanoclavine synthase, use an NADPH-independent superoxide mechanism, highlighting mechanistic diversity.
• NADPH-binding motifs are conserved across evolution and can be dissected structurally and phylogenetically.
• CRISPR-based editing of NADPH-binding residues enables causal tests of coenzyme selectivity in cells.
NADPH binding: mechanism, structure, and molecular function
What Happens During NADPH binding?
In simple terms: NADPH binding is the step where a protein grabs the reduced coenzyme NADPH and holds it in a pocket so it can donate electrons or trigger a shape change.
During NADPH binding, the protein's binding pocket recognizes the NADPH molecule through a combination of hydrogen bonds, electrostatic interactions, and hydrophobic contacts. The 2'-phosphate group of the adenosine ribose is a key recognition element that distinguishes NADPH from NADH. Binding can be accompanied by conformational rearrangements; for example, the phagocyte NADPH oxidase complex undergoes large-scale activation-associated changes upon NADPH engagement. In some proteins, binding is rapid and reversible, as shown by thermodynamic and NMR analyses of NADPH binding to lipocalin-type prostaglandin D synthase. In others, binding is coupled to subunit assembly or membrane recruitment.
Structure and Composition of NADPH binding
In simple terms: The NADPH-binding site is usually a folded pocket built from a Rossmann-like domain that cradles the coenzyme.
The structural basis of NADPH binding is best exemplified by the Rossmann fold, a dinucleotide-binding domain that uses a glycine-rich loop to position the pyrophosphate and adenosine moieties. Crystallographic analysis of glutathione reductase bound to NADPH, NADPH fragments, and analogues revealed the precise interactions that define coenzyme specificity. In the phagocyte NADPH oxidase, multiple subunits contribute to the NADPH-binding site, and the activated-state structure shows how the coenzyme is coordinated within the assembled complex. In voltage-gated K+ channels, the Kvbeta subunit provides an NADPH-binding site that is structurally distinct from classical Rossmann-fold enzymes. These examples illustrate that NADPH-binding sites can be built from diverse protein folds but share the requirement to recognize the 2'-phosphate.
Molecular Mechanism of NADPH binding
In simple terms: At the molecular level, NADPH binding positions the coenzyme so that its hydride can be transferred to a substrate or so that the protein changes shape.
The molecular mechanism of NADPH binding involves substrate-assisted positioning of the nicotinamide ring for hydride transfer. In glutathione reductase, the bound NADPH is oriented so that the C4 of the nicotinamide ring faces the disulfide substrate, enabling efficient electron transfer. In glutamate dehydrogenase, spectroscopic characterization showed that NADH and NADPH bind with different affinities and induce distinct spectral changes, reflecting differences in their binding modes. For lipocalin-type prostaglandin D synthase, thermodynamic and NMR analyses demonstrated that NADPH binding is accompanied by specific structural and dynamic changes. In the phagocyte NADPH oxidase, NADPH binding is coupled to electron transfer through FAD and heme centers to generate superoxide. In contrast, chanoclavine synthase operates by an NADPH-independent superoxide mechanism, showing that not all redox enzymes require NADPH binding for catalysis.
Cofactors and Regulation of NADPH binding
In simple terms: NADPH binding can be tuned by other cofactors and by regulatory subunits that change how tightly or how often the coenzyme binds.
NADPH binding is often regulated by the availability of other cofactors and by protein-protein interactions. In the phagocyte NADPH oxidase, assembly of cytosolic and membrane subunits is required before productive NADPH binding and electron transfer can occur. In voltage-gated K+ channels, NADPH binding to the beta-subunit regulates channel inactivation, linking coenzyme levels to electrical signaling. The evolutionary dissection of NADPH-binding motifs in ene-reductases has shown that sequence variation in the motif tunes coenzyme preference and catalytic efficiency. These examples indicate that NADPH binding is not a static property but a regulated interaction that can be modulated by cellular context.
Key Genes Involved in GO:0070402 NADPH binding
The following genes and proteins represent well-characterized examples of NADPH-binding function across enzyme, channel, and oxidase systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSR | Glutathione reductase; uses NADPH to reduce oxidized glutathione | Crystallographic studies defined NADPH binding and coenzyme specificity. |
| CYBB | Phagocyte NADPH oxidase catalytic subunit (gp91phox) | Activated-state structure reveals NADPH coordination in the oxidase complex. |
| NCF1 | Phagocyte NADPH oxidase cytosolic subunit (p47phox) | Required for assembly and NADPH-dependent superoxide production. |
| NCF2 | Phagocyte NADPH oxidase cytosolic subunit (p67phox) | Contributes to activation of NADPH oxidase and electron transfer. |
| KCNAB1 | Voltage-gated K+ channel beta subunit | NADPH binding regulates channel inactivation. |
| KCNAB2 | Voltage-gated K+ channel beta subunit | NADPH binding modulates K+ channel gating. |
| PTGDS | Lipocalin-type prostaglandin D synthase | NADPH binding characterized by thermodynamics and NMR. |
| GLUD1 | Glutamate dehydrogenase 1 | Binds NADH and NADPH with distinct spectroscopic signatures. |
| GLUD2 | Glutamate dehydrogenase 2 | Related dehydrogenase with NADPH-binding capability. |
| NQO1 | NAD(P)H quinone dehydrogenase 1 | Uses NADPH as electron donor in detoxification. |
| TXNRD1 | Thioredoxin reductase 1 | NADPH-dependent disulphide reductase. |
| TXNRD2 | Thioredoxin reductase 2 | NADPH-dependent mitochondrial disulphide reductase. |
| GSR2 | Glutathione reductase paralog | NADPH-dependent disulphide reduction. |
| CYPOR | Cytochrome P450 oxidoreductase | NADPH-binding flavoprotein that supplies electrons to P450s. |
| FNR | Ferredoxin-NADP+ reductase | NADPH-binding enzyme in redox metabolism. |
| ENR | Ene-reductase family | NADPH-binding motifs dissected structurally and evolutionarily. |
| EasC | Chanoclavine synthase | NADPH-independent superoxide mechanism. |
How Is NADPH binding Regulated?
NADPH binding is regulated at multiple levels. Protein-protein interactions control assembly of the phagocyte NADPH oxidase, which is a prerequisite for productive NADPH binding and superoxide generation. Subunit composition can also modulate binding, as in voltage-gated K+ channels where the Kvbeta subunit confers NADPH sensitivity and regulates inactivation. Sequence variation within NADPH-binding motifs tunes coenzyme preference and catalytic activity in ene-reductases. In addition, the cellular ratio of NADPH to NADP+ influences the occupancy of NADPH-binding sites and the flux through reductive pathways. These regulatory layers ensure that NADPH binding is matched to metabolic demand and signaling context.
NADPH binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYBB | Chronic granulomatous disease; defective superoxide production | Knockout or point-mutation in phagocyte-like cells; oxidase activity assay |
| NCF1 | Chronic granulomatous disease; impaired oxidase assembly | Knockout in neutrophil-like HL-60 cells; NADPH binding assay |
| GSR | Oxidative stress susceptibility; altered glutathione homeostasis | Knockout or point-mutation in hepatocytes; glutathione reduction assay |
| KCNAB1 | Channelopathy-related electrical dysfunction | Knock-in of NADPH-binding mutation; patch-clamp electrophysiology |
| TXNRD1 | Cancer redox adaptation; chemoresistance | Overexpression or knockout in cancer cell lines; thioredoxin reduction assay |
NADPH binding and chronic granulomatous disease
Defects in the phagocyte NADPH oxidase complex, which requires NADPH binding for superoxide production, cause chronic granulomatous disease, an immunodeficiency characterized by recurrent bacterial and fungal infections. Structural analysis of the activated oxidase provides a framework for understanding how mutations affecting NADPH binding or electron transfer lead to loss of respiratory burst activity.
NADPH binding and oxidative stress-related disorders
NADPH-dependent disulphide reductases, including glutathione reductase and thioredoxin reductases, rely on NADPH binding to maintain cellular redox homeostasis. Impaired NADPH binding or reduced coenzyme availability can shift the balance toward oxidative stress, which is implicated in neurodegeneration, cardiovascular disease, and aging.
NADPH binding and channelopathies
NADPH binding to Kvbeta subunits regulates voltage-gated K+ channel inactivation, linking coenzyme binding to electrical excitability. Dysregulation of this interaction may contribute to channelopathies affecting neuronal or cardiac function, although direct disease associations require further study.
NADPH binding in cancer metabolism
Cancer cells often upregulate NADPH-producing and NADPH-consuming pathways to support biosynthesis and manage oxidative stress. NADPH-binding enzymes such as glutathione reductase and thioredoxin reductase are therefore considered potential targets for anticancer strategies, and their binding sites are being explored for inhibitor development.
From NADPH binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the NADPH-binding motif required for enzyme catalysis? | CRISPR knockout of the motif or point mutation of the glycine-rich loop |
| Does a specific NADPH-binding residue determine coenzyme selectivity? | Point mutation of the 2'-phosphate-binding residue followed by NADPH/NADH binding assays |
| Can a disease-associated mutation be corrected at the NADPH-binding site? | Knock-in of the wild-type sequence or base editing in patient-derived cells |
| Does NADPH binding regulate ion channel gating? | Knock-in of NADPH-binding-deficient Kvbeta and patch-clamp recording |
| What is the effect of NADPH-binding protein overexpression on redox balance? | Overexpression of GSR or TXNRD1 in cell lines followed by redox measurements |
| Which genes are required for phagocyte superoxide production? | Genome-wide CRISPR knockout library screening in phagocyte-like cells |
How to Study the NADPH binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of NADPH-protein complex | Defining binding pocket and coenzyme specificity |
| Cryo-EM | Structure of large NADPH-binding complexes | Activated-state phagocyte NADPH oxidase |
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Quantifying NADPH binding to enzymes |
| NMR spectroscopy | Conformational changes upon NADPH binding | Lipocalin-type prostaglandin D synthase |
| UV/Vis spectroscopy | NADPH oxidation or spectral shifts | Glutamate dehydrogenase binding modes |
| Enzyme activity assay | NADPH consumption or substrate reduction | Glutathione reductase and thioredoxin reductase |
| CRISPR knockout screening | Genes required for NADPH-dependent phenotypes | Phagocyte superoxide production |
| Bioinformatics motif analysis | Conservation and evolution of NADPH-binding motifs | Ene-reductase family |
Structural biology of NADPH binding
X-ray crystallography and cryo-EM are used to determine how NADPH is coordinated within a protein's binding pocket. Crystallographic analysis of glutathione reductase with NADPH and analogues revealed the molecular details of coenzyme recognition, and the activated-state structure of the phagocyte NADPH oxidase showed how NADPH is bound within the assembled complex. These methods provide atomic-level maps of the binding site and guide mutagenesis studies.
Biochemical and biophysical binding assays
NADPH binding affinity and thermodynamics can be measured using spectroscopic and calorimetric methods. Spectroscopic characterization of glutamate dehydrogenase distinguished NADH and NADPH binding modes, while thermodynamic and NMR analyses resolved NADPH binding to lipocalin-type prostaglandin D synthase. These approaches quantify binding constants and detect conformational changes coupled to coenzyme binding.
Functional assays for NADPH-dependent activity
Enzymatic assays measure the consumption of NADPH or the reduction of substrates to assess the functional consequences of NADPH binding. Glutathione reductase activity is monitored by NADPH oxidation, and phagocyte NADPH oxidase activity is measured by superoxide production. These assays are essential for linking binding to catalysis.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout screens can identify genes required for NADPH-dependent processes such as superoxide production or redox homeostasis. Bioinformatics analyses of NADPH-binding motifs, including structural and evolutionary dissection, reveal conserved sequence features and coenzyme preferences. Combined with transcriptomic and proteomic data, these methods prioritize candidate genes for functional validation.
How CRISPR Can Be Used to Study GO:0070402 NADPH binding
Knockout
CRISPR knockout of genes encoding NADPH-binding proteins can abolish coenzyme-dependent activities, such as superoxide production in phagocyte-like cells. Knockout of glutathione reductase or thioredoxin reductase genes impairs redox homeostasis and sensitizes cells to oxidative stress. These models are used to test whether a specific NADPH-binding protein is required for a given phenotype.
Point Mutation
Point mutations targeting the glycine-rich NADPH-binding motif or the 2'-phosphate recognition residues can selectively disrupt NADPH binding without eliminating protein expression. Such mutants are valuable for dissecting coenzyme selectivity and for testing whether binding is required for catalysis or regulation.
Knock-in
Knock-in of disease-associated or wild-type NADPH-binding sequences allows precise modeling of human variants. For example, correcting a mutation in the phagocyte NADPH oxidase complex can restore NADPH binding and superoxide production in patient-derived cells. Knock-in of NADPH-binding-deficient Kvbeta variants enables electrophysiological studies of channel regulation.
Overexpression
Overexpression of NADPH-binding enzymes such as glutathione reductase or thioredoxin reductase can increase reductive capacity and alter sensitivity to oxidative stress. Overexpression models are used to test whether increased NADPH binding capacity is sufficient to drive a phenotype, such as chemoresistance in cancer cells.
How EDITGENE Supports NADPH binding Research
Researchers studying NADPH binding-related genes often need to determine whether a candidate gene is causally involved in a redox, metabolic, or signaling phenotype. EDITGENE provides CRISPR-based cell model services that enable precise interrogation of NADPH-binding function, from complete knockout to single-residue point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for NADPH binding research.
Frequently Asked Questions About NADPH binding
What is NADPH binding (GO:0070402)?
NADPH binding is a molecular function defined as binding to the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions.
What genes are involved in NADPH binding?
Genes encoding NADPH-binding proteins include GSR, CYBB, NCF1, NCF2, KCNAB1, KCNAB2, PTGDS, GLUD1, TXNRD1, and TXNRD2, among others.
How does NADPH binding differ from NADH binding?
NADPH binding proteins recognize the 2'-phosphate group on the adenosine ribose, which distinguishes NADPH from NADH and determines coenzyme selectivity.
What is the Rossmann fold in NADPH binding?
The Rossmann fold is a dinucleotide-binding domain with a glycine-rich motif that coordinates the NADPH pyrophosphate and adenosine moieties.
Which diseases are linked to NADPH binding defects?
Defects in the phagocyte NADPH oxidase cause chronic granulomatous disease, and impaired NADPH-dependent reductases are linked to oxidative stress-related disorders and cancer metabolism.
Can NADPH binding regulate ion channels?
Yes, NADPH binding to the Kvbeta subunit regulates inactivation of voltage-gated K+ channels.
Do all redox enzymes require NADPH binding?
No, some enzymes such as chanoclavine synthase operate by an NADPH-independent superoxide mechanism.
How can I study NADPH binding with CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of NADPH-binding residues and their functional consequences.
What methods measure NADPH binding affinity?
Isothermal titration calorimetry, NMR spectroscopy, and UV/Vis spectroscopy are commonly used to quantify NADPH binding and detect conformational changes.
Why is NADPH binding important for antioxidant defense?
NADPH binding enables glutathione reductase and thioredoxin reductases to reduce disulphide bonds, maintaining cellular redox homeostasis.
Conclusion
GO:0070402 NADPH binding is a central molecular function that connects coenzyme recognition to reductive biosynthesis, antioxidant defense, immune superoxide production, and ion channel regulation. Structural and biochemical studies have defined the Rossmann-fold motif and 2'-phosphate specificity pocket that distinguish NADPH from NADH, while thermodynamic and NMR analyses have revealed binding-coupled conformational changes. The diversity of NADPH-binding proteins, from glutathione reductase to the phagocyte oxidase and Kvbeta subunits, underscores its broad biological importance. CRISPR-based cell models now make it possible to test the causal role of NADPH-binding residues in health and disease, from chronic granulomatous disease to cancer redox adaptation. By combining knockout, point-mutation, knock-in, overexpression, and library screening approaches, researchers can dissect coenzyme selectivity and identify therapeutic targets within NADPH-binding sites. EDITGENE provides the tools and expertise to accelerate these studies.
References
- 1. Liu X et al.. 2024. Structure of human phagocyte NADPH oxidase in the activated state.. Nature 627(8002):189-195 PMID: 38355798
- 2. Kerschbaumer B et al.. 2026. Structural and evolutionary dissection of NADPH-binding motifs in NADPH-preferring ene-reductases.. Protein Sci 35(4):e70521 PMID: 41848427
- 3. Tipparaju SM et al.. 2007. NADPH binding to beta-subunit regulates inactivation of voltage-gated K(+) channels.. Biochem Biophys Res Commun 359(2):269-76 PMID: 17540341
- 4. Pai EF et al.. 1988. Crystallographic analysis of the binding of NADPH, NADPH fragments, and NADPH analogues to glutathione reductase.. Biochemistry 27(12):4465-74 PMID: 2844232
- 5. Delabar JM et al.. 1982. The binding of NADH and NADPH to bovine-liver glutamate dehydrogenase. Spectroscopic characterisation.. Eur J Biochem 127(2):367-74 PMID: 7140774
- 6. Qin S et al.. 2015. Thermodynamic and NMR analyses of NADPH binding to lipocalin-type prostaglandin D synthase.. Biochem Biophys Res Commun 468(1-2):234-9 PMID: 26518650
- 7. Chen CC et al.. 2025. Chanoclavine synthase operates by an NADPH-independent superoxide mechanism.. Nature 640(8059):840-846 PMID: 40044871
- 8. Krauth-Siegel RL et al.. 1989. NADPH-dependent disulphide reductases.. Biochem Soc Trans 17(2):315-7 PMID: 2666188
